高级搜索

腹膜后肿瘤临床病理特征与诊治分析

苗成利, 何远翔, 李玉坤, 蒋彦永, 于军辉, 刘星, 罗成华

苗成利, 何远翔, 李玉坤, 蒋彦永, 于军辉, 刘星, 罗成华. 腹膜后肿瘤临床病理特征与诊治分析[J]. 肿瘤防治研究, 2015, 42(08): 797-800. DOI: 10.3971/j.issn.1000-8578.2015.08.010
引用本文: 苗成利, 何远翔, 李玉坤, 蒋彦永, 于军辉, 刘星, 罗成华. 腹膜后肿瘤临床病理特征与诊治分析[J]. 肿瘤防治研究, 2015, 42(08): 797-800. DOI: 10.3971/j.issn.1000-8578.2015.08.010
MIAO Chengli, HE Yuanxiang, LI Yukun, JIANG Yanyong, YU Junhui, LIU Xing, LUO Chenghua. Clinicopathological Features and Diagnosis of Retroperitoneal Tumor[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 797-800. DOI: 10.3971/j.issn.1000-8578.2015.08.010
Citation: MIAO Chengli, HE Yuanxiang, LI Yukun, JIANG Yanyong, YU Junhui, LIU Xing, LUO Chenghua. Clinicopathological Features and Diagnosis of Retroperitoneal Tumor[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 797-800. DOI: 10.3971/j.issn.1000-8578.2015.08.010

腹膜后肿瘤临床病理特征与诊治分析

详细信息
    作者简介:

    苗成利(1979-),男,博士,主治医师,主要从事腹膜后肿瘤手术及基础研究

    通讯作者:

    罗成华,E-mail:luochenghua@pkuih.edu.cn

  • 中图分类号: R735.5

Clinicopathological Features and Diagnosis of Retroperitoneal Tumor

  • 摘要: 目的 探讨腹膜后肿瘤的临床病理特点,总结腹膜后肿瘤诊治经验。方法 回顾性分析了1975年9月—2014年12月间收集的687例腹膜后肿瘤患者资料,并进行临床病理特征及术后复发影响因素的分析。结果 687例腹膜后肿瘤患者中,良性173例(25.2%),交界性44例(6.4%),恶性470例(68.4%)。原发性腹膜后恶性肿瘤中常见的为脂肪肉瘤、平滑肌肉瘤、恶性纤维组织细胞瘤,分别占全部腹膜后肿瘤11.6%、8.7%、4.4%。良性肿瘤常见的为畸胎瘤,占全部肿瘤5%。原发性肿瘤592例,占86.2%。继发性肿瘤95例,占13.8%。腹膜后肿瘤临床表现多样,术中出血多,术中联合脏器切除的概率高。肿瘤性质、肿瘤切除程度、肿瘤分化程度是腹膜后肿瘤术后复发的主要影响因素(P<0.05)。肿瘤切除愈彻底,复发时间愈晚。结论 提高腹膜后恶性肿瘤的完全切除率,降低腹膜后肿瘤术后复发,是治疗腹膜后肿瘤的关键措施。

     

    Abstract: Objective To discuss the clinicopathological characteristics of retroperitoneal tumors(RPT), and summarize the experience of diagnosis and treatment. Methods We reviewed and analyzed the data of 687 RPT patients between September 1975 to December 2014. Results RPT pathological type was complex: benign tumour: 173 cases, low-grade malignant tumor:44 cases, and malignant tumor: 470 cases. The common primary malignant RPT was liposarcoma(11.6%), leiomyosarcoma(8.7%), malignant fibrous histiocytoma(4.4%). Tumor pathological type was also complex: common benign tumor was teratoma: 5.0%, total benign tumor: 25.2%, borderline tumor: 6.4%, malignant tumor: 68.4%. Primary RPT(592 cases)accounted for 86.2%. Secondary RPT(95 cases)accounted for 13.8%. The clinical manifestation of RPT was complex: the incidence of hemorrhage during operation and viscera combined resection was high. Tumor characteristic, resection degree, differentiation degree were the influence factors for postoperative recurrence of RPT(P<0.05). Conclusion Improving the complete resection of retroperitoneal malignant tumor is the main measure to reduce tumor recurrence and treat the retroperitoneal tumors.

     

  • [1] Luo CH. Retroperutoneal Tumor[M]. Beijing: People’s Medical Publishing House, 2013: 1-3. [罗成华. 腹膜后肿瘤[M]. 北京: 人 民卫生出版社, 2013: 1-3.]
    [2] Tseng WW. Madewell JE, Wei W, et al. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection?[J]. Ann Surg Oncol, 2014, 21(7): 2136-43.
    [3] Clark MA, Fisher C, Judson I, et al. Soft-tissue sarcomas in adults[J]. New Engl J Med, 2005, 353(7): 701-11.
    [4] Long ZW, XuY, Liu XW, et al. Clinical analnysis of 200 cases primary retroperitoneal tumors[J]. Zhongguo Shi Yong Wai Ke Za Zhi, 2013, 33(2): 127-29. [龙子雯, 徐宇, 刘晓文, 等. 原发性腹 膜后肿瘤200例诊治分析[J]. 中国实用外科杂志, 2013, 33(2): 12 7-29.]
    [5] Chen CC, Guo XF, Yuan ZL, et al. The CT imaging characteristics of retroperitoneal non-functional paraganglioma[J]. Zhong Liu Fang Zhi Yan Jiu, 2014, 41(6): 667-8. [陈长春, 郭小芳, 袁子龙, 等. 腹膜后非功能性副神经-节瘤的CT影像学特点[J]. 肿瘤防 治究, 2014, 41(6): 667-8.]
    [6] Jiang H, wang YX, Li B, et al. Surgical management of leiomysarcoma of the inferior vena cava[J]. Vascular, 2015, 23(3): 32 9-32.
    [7] Patschan D, Müller GA. Acute kidney injury[J]. J Inj Violence Res, 20 15, 7(1): 19-26.
    [8] Liu Y, Sun Y, Jiang, et al. A novel strategy of vascular reconstruction after radical resection of an inferior vena cava leiomyosarcoma[J]. Ann Vasc Surg, 2013, 27(6): 803.
    [9] Li B, Luo CH, Zheng W. Risk factors for recurrence and survival in patients with primary retroperitoneal tumors[J]. J BUON, 2013, 18 (3): 782-7.
    [10] Crago AM, Singer S. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma[J]. Curr Opin Oncol, 2011, 23(4): 373-8.
    [11] Engström K, Bergh P, Gustafson P, et al. Liposarcoma: outcome based on the Scandinavian Sarcoma Group register[J]. Cancer, 20 08, 113(7): 1649-56.
    [12] Miao C, Liu D, Zhang F, et al. Association of FPGS genetic polymorphisms with primary retroperitoneal liposarcoma[J]. Sci Rep, 2015, 5: 9079.
计量
  • 文章访问数:  2034
  • HTML全文浏览量:  484
  • PDF下载量:  1127
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-06-17
  • 修回日期:  2015-07-05
  • 刊出日期:  2015-08-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭